Welcome



Join ArisGlobal’s CEO for an inside look at the trends transforming life sciences. Discover how AI, decision intelligence, and a connected ecosystem are helping organizations accelerate innovation, improve productivity, and drive measurable outcomes, while getting a first look at the next wave of ArisGlobal innovation.
Join industry IT leaders for a discussion on how AI, connected data ecosystems, and modern platforms are transforming clinical, manufacturing, safety, regulatory, quality, and medical affairs operations.
Be among the first to experience what’s next for XDI, NavaX, and LifeSphere. At BT27, our leaders will showcase the upcoming product advancements, highlighting how these new capabilities coming in the months ahead will accelerate decision-making, streamline operations, and create a more connected drug development ecosystem.

Explore the journey toward predictive PV, where AI-powered insights, connected data, and advanced analytics help organizations identify emerging risks earlier and make more informed safety decisions across the product lifecycle.

The future of life sciences will be defined by AI-driven insights, connected data, and seamless collaboration. This keynote explores a unified, end-to-end platform that empowers organizations to transform R&D operations, streamline compliance, and unlock the full value of their data. Discover how AI is enabling faster innovation, smarter decisions, and a more proactive approach across the entire development lifecycle.
Learn the key mindset and process changes needed to successfully adopt AI and agents in PV and Regulatory, including workflow redesign, human oversight, governance, and workforce readiness.
How do you choose a regulatory platform built for the future? Hear regulatory leaders share their evaluation journey, selection criteria, and why they chose LifeSphere Regulatory to power a more connected, AI-enabled regulatory organization.

Discover how ArisGlobal’s NavaX-powered QMS drives automation, connected workflows, and cross-functional intelligence to transform quality operations and accelerate compliance.

Learn how Amgen successfully modernized its global safety landscape through a large-scale implementation of the full E2E LifeSphere Safety Suite. This session will highlight key milestones, migration strategies, integration challenges, and the role of AI-powered innovation in creating a connected, future-ready pharmacovigilance platform.
Explore how modern safety organizations are transforming fragmented data into actionable insights. This session covers advances in signal detection, AI-assisted prioritization, decision traceability, and outcome measurement to help teams improve decision-making, strengthen confidence, and drive greater business impact.

Explore how organizations are balancing AI innovation with compliance by establishing robust governance, risk management, and validation frameworks aligned to emerging global regulatory principles.
Join us as we recognize the organizations and individuals setting new standards for innovation across life sciences. These award winners have demonstrated exceptional leadership in embracing digital transformation, advancing AI-powered operations, improving patient outcomes, and delivering measurable business impact.



In today’s competitive landscape, great ideas need more than passion. They need proof. This session equips professionals with strategies to build a persuasive business case that speaks the language of decision-makers. Learn how to quantify return on investment (ROI), demonstrate measurable time savings, and highlight quality improvements that drive stakeholder buy-in.
The future of life sciences depends on connected intelligence. Hear how leading pharma organizations are leveraging interoperable PV and regulatory platforms to create seamless data exchange, enhance compliance, and drive smarter, faster safety and regulatory outcomes.
Join this keynote session to hear insights from the front lines of the NavaX journey. Learn what it takes to successfully implement and scale a modern safety platform, from driving organizational change and user adoption to realizing the full value of AI-powered automation. Discover key lessons, best practices, and a vision for how NavaX is helping organizations transform safety operations and prepare for the future of pharmacovigilance.
Discover how the AI-powered intake of ReporterX is helping life sciences organizations improve the quality and completeness of adverse event and product quality complaint reporting from the very first interaction. Learn how conversational AI, multilingual processing, and intelligent follow-up management can reduce manual effort, enhance compliance, and streamline downstream safety and quality operations.

Aggregate reporting is evolving beyond manual, document-centric processes. This session explores how ArisGlobal’s Advanced Compliance Documents uses automation, data traceability, and standardized workflows to streamline the creation of PSURs, PBRERs, DSURs, and other regulatory reports, improving consistency, accelerating review cycles, and enabling faster, more confident submissions.
Learn how leading life sciences organizations are moving from reactive audit preparation to continuous inspection readiness. Explore how automation, real-time compliance monitoring, and streamlined documentation management can reduce operational burden, strengthen regulatory compliance, and improve inspection outcomes in an increasingly complex regulatory environment.
As global IDMP requirements evolve, maintaining compliant product data is more critical than ever. Join ArisGlobal experts to learn how SPORIFY simplifies reference data management, automates EMA SPOR synchronization, and accelerates IDMP readiness while reducing manual effort and improving data quality.
Life sciences organizations are rich in data but often challenged by disconnected information across R&D. Join this session to discover how a unified decision intelligence layer connects data, context, and institutional knowledge to deliver faster, more informed decisions across life sciences.
With rising development costs and increasing pressure to maximize R&D returns, life sciences organizations are rethinking how technology drives business value. Hear from industry leaders on how AI, connected data, and intelligence are driving operational improvements.
